poisar

Stocks · News reference

TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5

BenzingaAug 7, 2026, 9:09 PMBenzinga Newsdesk

TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 7, 2026, 9:09 PM
Checked
Aug 7, 2026, 9:09 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading